Digestive diseases and sciences

publication venue for

Capsule-induced small-bowel obstruction during video capsule endoscopy in a patient with carcinomatosis. 2009
Humoral hypercalcemia complicating adenosquamous carcinoma of the proximal colon. 1989
Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.. 69. 2024
A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis. 2024
Nicotinamide Riboside Improves Enteric Neuropathy in Streptozocin-Induced Diabetic Rats Through Myenteric Plexus Neuroprotection.. 68. 2023
A National Survey of the Infrastructure and Scope of Practice for Gastroenterology Hospitalists. 2023
Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey. 2022
Characteristics of 30-Day All-Cause Hospital Readmissions Among Patients with Acute Pancreatitis and Substance Use. 2022
Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.. 67. 2021
De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.. 67. 2021
Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.. 67. 2021
Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy. 2021
Comparative Efficacy of Transcutaneous Functional Electrical Stimulation With or Without Biofeedback Therapy on Functional Non-retentive Fecal Incontinence in Children: A Randomized Clinical Trial.. 67. 2021
Morphologic Severity of Acute Pancreatitis on Imaging Is Independently Associated with Opioid Dose Requirements in Hospitalized Patients.. 67. 2021
Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.. 67. 2021
Impact of Fellow Participation During Colonoscopy on Adenoma Detection Rates.. 67. 2021
Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.. 66. 2020
Factors Associated with Up-to-Date Colonoscopy Use Among Puerto Ricans in New York City, 2003-2016.. 66. 2020
Characteristics and Outcomes of Patients Undergoing Endoscopy During the COVID-19 Pandemic: A Multicenter Study from New York City.. 66. 2020
Does Provider Type Affect Bone Health Surveillance in Chronic Pancreatitis?. 66. 2020
Rectal Distension Increased the Rectoanal Gradient in Patients with Normal Rectal Sensory Function.. 66. 2020
Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.. 66. 2020
Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.. 66. 2020
Chronic Pancreatitis Patients Who Leave Against Medical Advice: Prevalence, Trend, and Predictors.. 66. 2020
Impact of a Citywide Benchmarking Intervention on Colonoscopy Quality Performance.. 65. 2020
Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.. 65. 2019
Opiate Prescriptions at Discharge Are Not Associated with Early Readmissions in Acute Pancreatitis.. 65. 2019
Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.. 65. 2019
Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort.. 65. 2019
Early Endoscopy Is Associated with Better Clinical Outcomes in Patients Hospitalized with Ischemic Bowel Disease.. 64. 2019
Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.. 64. 2019
Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage.. 64. 2019
Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.. 64. 2018
PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.. 63. 2018
Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.. 64. 2018
Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.. 63. 2018
Achalasia Patients Are at Nutritional Risk Regardless of Presenting Weight Category.. 63. 2018
Role of Fluorescent In Situ Hybridization, Cholangioscopic Biopsies, and EUS-FNA in the Evaluation of Biliary Strictures.. 63. 2018
Skepticism Regarding Vaccine and Gluten-Free Food Safety Among Patients with Celiac Disease and Non-celiac Gluten Sensitivity.. 63. 2017
Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.. 62. 2017
A Novel Protocol Obviates Endoscope Sampling for Carbapenem-Resistant Enterobacteriaceae: Experience of a Center with a Prior Outbreak.. 62. 2017
Prevalence and Predictors of Giardia in the United States.. 62. 2017
Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.. 61. 2016
Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.. 61. 2015
Exercise and Self-Reported Limitations in Patients with Inflammatory Bowel Disease.. 61. 2015
Probe-Based Confocal Endomicroscopy in Primary Sclerosing Cholangitis: Not All Inflammatory Strictures Are the Same.. 61. 2015
Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry.. 60. 2015
Impact of microscopic duodenitis on symptomatic response to Helicobacter pylori eradication in functional dyspepsia.. 60. 2014
Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?. 59. 2014
Statin use in patients with cirrhosis: a retrospective cohort study.. 59. 2014
Sporadic duodenal adenoma and association with colorectal neoplasia: a case-control study.. 59. 2014
Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.. 59. 2014
Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.. 59. 2014
Is pyloric gland metaplasia in ileal pouch biopsies a marker for Crohn's disease?. 58. 2013
Interpretation of probe-based confocal laser endomicroscopy of indeterminate biliary strictures: is there any interobserver agreement?. 57. 2012
Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.. 57. 2012
Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.. 57. 2012
Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.. 57. 2012
Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease.. 56. 2011
Detection of esophageal varices using CT and MRI.. 56. 2011
Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis.. 56. 2011
Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.. 56. 2010
Live view video capsule endoscopy enables risk stratification of patients with acute upper GI bleeding in the emergency room: a pilot study.. 56. 2010
Association of intussusception and celiac disease in adults.. 55. 2009
A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.. 55. 2009
Predicting malignant potential of gastrointestinal stromal tumors using endoscopic ultrasound.. 54. 2008
Chronic hepatitis C virus and celiac disease, is there an association?. 53. 2007
A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma.. 52. 2007
Prognostic significance of hepatitis C virus RNA detection by transcription-mediated amplification with negative polymerase chain reaction during therapy with peginterferon alpha and ribavirin.. 52. 2007
Multiplex cytokine profiling of initial therapeutic response in patients with chronic hepatitis C virus infection.. 50. 2005
Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety.. 50. 2005
Persistent CEA elevation in a patient with psoriasis and a history of metastatic colorectal cancer with no evidence of residual tumor.. 49. 2004
Role of duodenum on sphincter of Oddi motility in conscious dogs.. 48. 2003
Diffuse esophageal spasm: not diffuse but distal esophageal spasm (DES).. 48. 2003
Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats.. 46. 2001
Role of esophageal function tests in diagnosis of gastroesophageal reflux disease.. 46. 2001
Noninvasive in vivo analysis of human small intestinal paracellular absorption: regulation by Na+-glucose cotransport.. 45. 2000
Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.. 45. 2000
Evaluation of effects of ethyl alcohol and bismuth subsalicylate on gastric mucosal barrier in man.. 44. 1999
Factors affecting outcome following proximal and distal intestinal resection in the dog: an examination of the relative roles of mucosal adaptation, motility, luminal factors, and enteric peptides.. 44. 1999
Pneumatic dilatation is effective long-term treatment for achalasia.. 43. 1998
Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux.. 43. 1998
Qualitative changes in enteric flora and short-chain fatty acids after intestinal resection.. 43. 1998
Smooth muscle adaptation after intestinal transection and resection.. 41. 1996
An evaluation of an ambulatory manometry system in assessment of antroduodenal motor activity.. 41. 1996
Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.. 41. 1996
Validation of a new measure of diarrhea.. 40. 1995
Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress.. 40. 1995
Regional variation in canine intestinal muscle mass and function.. 40. 1995
Response to intraluminal gas in irritable bowel syndrome. Motility versus perception.. 40. 1995
Effect of alpha 1-adrenergic blockade on canine ileal water, electrolyte, and glucose absorption.. 39. 1994
Effects of jejunoileal autotransplantation on gastrointestinal regulatory peptides.. 39. 1994
Effects of artificial ileocolonic sphincter on motility in intestinal remnant following subtotal small intestinal resection in the dog.. 39. 1994
Prevalence of gallstone disease in Mexico. A necropsy study.. 38. 1993
Omeprazole-induced hypergastrinemia does not influence growth of colon carcinoma.. 37. 1992
Antroduodenal manometry. Usefulness and limitations as an outpatient study.. 37. 1992
Long-term effects of jejunoileal autotransplantation on myoelectrical activity in canine small intestine.. 35. 1990
Gastric emptying of liquids and solids in the portal hypertensive rat.. 35. 1990
Disruption of canine jejunal interdigestive myoelectrical activity by artificial ileocolonic sphincter. Studies of intestinal motor response to surgically fashioned sphincter substitute.. 34. 1989
Ogilvie's syndrome. Successful management without colonoscopy.. 33. 1988
Acid-induced esophagitis in cats is prevented by sucralfate but not synthetic prostaglandin E.. 33. 1988
Upper gastrointestinal neoplasia in familial polyposis.. 32. 1987
Effects of exogenous secretin on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma secretin levels.. 30. 1985
Esophageal motility and symptoms after endoscopic injection sclerotherapy.. 30. 1985
Kaposi's sarcoma. Gastrointestinal involvement correlation with skin findings and immunologic function.. 29. 1984
Effects of exogenous glucagon on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma glucagon.. 28. 1983
Endoscopic manometry of pancreatic and biliary sphincter zones in man. Basal results in healthy volunteers.. 26. 1981
Pancreatic juice gamma-glutamyltransferase, alanine transaminase, and alkaline phosphatase in pancreatic disease.. 25. 1980
Laparoscopic diagnosis of suspected liver neoplasms. Value of prior liver scans.. 24. 1979
Comparison of flexible sigmoidoscopy with other diagnostic techniques in the diagnosis of rectocolon neoplasia.. 24. 1979
Antroduodenal manometry.. 37. 1992
Antroduodenal manometry.. 37. 1992
Ambulatory pH monitoring: how to truly test the patient? 2000
Gluten-Free Diet-What's Good for Celiac Disease Can Be Bad for Metabolism. 2024
PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn's Disease. 2023
Disparities in Telehealth for Liver Disease: Revealing What Was Hidden in Plain Sight. 2021
Is Tissue Really the Issue? How the Polyp Detection Rate May Be a Good Enough Quality Measure Among Trainees.. 65. 2020
Crohn's recurrence after intestinal resection and anastomosis.. 59. 2014
Open channels for functional bowel disorders: guanylate cyclase C agonists in IBS and CC.. 58. 2013
Management of Thrombocytopenia in Patients with Chronic Liver Disease. 2019
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. 2016
Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease. 2015
Medical and surgical complications of inflammatory bowel disease in the elderly: a systematic review. 2014
Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis. 2013
Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors. 1998
Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility. 1993
Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder. 1993
Intestinal manometry--technical advances, clinical limitations. 1992
Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis. 2023
Video Capsule Endoscopy and Device-Assisted Enteroscopy. 2021
Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis. 2021

VIVO Weill Cornell Medical College

Digestive diseases and sciences Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)